Target intelligence / Profile preview

4'-galactosyllactose-binding protein BbrY_0420 (BbrY_0420)

Target
BbrY_0420
Molecular classification
Transporter, Substrate-binding protein, ABC transporter component
01

Overview

4'-galactosyllactose-binding protein BbrY_0420 is a specialized solute-binding protein (SBP) found in Bifidobacterium breve strain Yakult (YIT 4014) (Source [1]). It serves as the primary recognition and capture component of an ATP-binding cassette (ABC) transporter system that enables the bacterium to utilize specific galacto-oligosaccharides (GOS) (Source [5]). The protein exhibits high substrate specificity and strong affinity for 4'-galactosyllactose (4'-GL) and 4-galactobiose (4-GB), specifically recognizing the Galβ1,4-Gal non-reducing terminal structure (Source [1]). BbrY_0420 is co-induced with the β-galactosidase BbrY_0422, ensuring that captured oligosaccharides are efficiently transported and subsequently hydrolyzed for energy (Source [1]). This transport system provides a competitive advantage for B. breve in the human colon, where it scavenges non-digestible dietary fibers that reach the lower gastrointestinal tract intact (Source [5]). By facilitating the selective growth of beneficial bifidobacteria, BbrY_0420 plays a crucial role in maintaining a healthy gut microbiome and modulating host immune responses (Source [5]). Increased abundance of B. breve mediated by this pathway is associated with reduced risks of enteric infection, chronic inflammation, and allergic diseases (Source [5]). Consequently, BbrY_0420 is a significant molecular target for prebiotic strategies and nutritional interventions aimed at fostering beneficial microbial populations for therapeutic benefit (Source [1], [7]).

Other names
Solute-binding protein BbrY_0420BbrY_04204'-GL-binding proteinBacterial substrate-binding protein BbrY_0420ABC transporter substrate-binding protein BbrY_0420
02

Mechanism of action

Selective binding and delivery of specific galacto-oligosaccharides to the transmembrane domains of an ABC transporter for cellular uptake and subsequent metabolic utilization (Source [1], [5]).

03

Biological functions

Carbohydrate transportPrebiotic utilizationBacterial colonizationNutrient acquisition
04

Disease associations

InfectionInflammationAllergyObesity
05

Safety considerations

Gastrointestinal discomfortBloatingFlatulence
06

Interacting drugs

Galacto-oligosaccharides

2 more in the full profile.

07

Biomarkers

Bifidobacterium breve abundanceFecal 4'-galactosyllactose levels

Beyond the preview

Go deeper on 4'-galactosyllactose-binding protein BbrY_0420 (BbrY_0420).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4'-galactosyllactose-binding protein BbrY_0420 (BbrY_0420).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call